On ECHEMI
Home > Drugs > Hubei Kelun Pharmaceutical Co., Ltd.
Hubei Kelun Pharmaceutical Co., Ltd.
  • Founded in:

    2006-07-04
  • Country:

    China China
  • Address:

    No. 29 Textile Avenue, Xiantao City, Hubei Province
  • Tax NO.:

    91429004790559537U
  • Registered Funds:

    30 million yuan
  • Website:

  • Email:

Related Drugs
Benzyl Alcohol Injection
The main component of this product is benzyl alcohol. Its chemical name is benzyl alcohol. Structural formula: Molecular formula: C7H8O Molecular weight 108.14
Name Description Content CAS NO. Registered Holders
Benzyl alcohol

It has local analgesic effect and antiseptic effect

More

It has local analgesic effect and antiseptic effect

100-51-6 20
Benzyl Alcohol Injection
The main component of this product is benzyl alcohol. Its chemical name is benzyl alcohol. Structural formula: Molecular formula: C7H8O Molecular weight 108.14
Name Description Content CAS NO. Registered Holders
Benzyl alcohol

It has local analgesic effect and antiseptic effect

More

It has local analgesic effect and antiseptic effect

100-51-6 20
Matrine Sodium Chloride Injection
The main ingredient of this product and its chemical name is: matrine.
Name Description Content CAS NO. Registered Holders
Matrine

It can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. It can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells, thus preventing cachexia in tumor patients.

More

It can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. It can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells, thus preventing cachexia in tumor patients.

519-02-8 8
Dexamethasone Sodium Phosphate Injection
Dexamethasone sodium phosphate. Its chemical name is: 16α-methyl-11β,17α,21-trihydroxy-9α-fluoropregnane-1,4-diene-3,20-dione-21-phosphate disodium salt.
Name Description Content CAS NO. Registered Holders
Dexamethasone sodium phosphate

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. Its mechanism of action is: 1. Anti-inflammatory effect: It reduces and prevents the tissue's response to inflammation, thereby reducing the manifestations of inflammation. It can inhibit the accumulation of inflammatory cells, including macrophages and leukocytes, at the site of inflammation, and inhibit phagocytosis, the release of lysosomal enzymes, and the synthesis and release of inflammatory chemical mediators. 2. Immunosuppressive effect: It includes preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, reducing the ability of immunoglobulins to bind to cell surface receptors, and inhibiting the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts.

More

Adrenal cortex hormone drugs. It has anti-inflammatory, anti-allergic, anti-rheumatic and immunosuppressive effects. Its mechanism of action is: 1. Anti-inflammatory effect: It reduces and prevents the tissue's response to inflammation, thereby reducing the manifestations of inflammation. It can inhibit the accumulation of inflammatory cells, including macrophages and leukocytes, at the site of inflammation, and inhibit phagocytosis, the release of lysosomal enzymes, and the synthesis and release of inflammatory chemical mediators. 2. Immunosuppressive effect: It includes preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, reducing the number of T lymphocytes, monocytes, and eosinophils, reducing the ability of immunoglobulins to bind to cell surface receptors, and inhibiting the synthesis and release of interleukins, thereby reducing the transformation of T lymphocytes into lymphoblasts.

55203-24-2 24
Isosorbide dinitrate and glucose injection
1,4:3,6-dianhydro-D-sorbitol dinitrate
Name Description Content CAS NO. Registered Holders
Isosorbide dinitrate

Relaxation of vascular smooth muscle, which in turn causes dilation of peripheral arteries and veins, has a stronger dilation effect on venous vessels. Venous dilation can promote peripheral blood aggregation and reduce venous return, thereby reducing ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Relaxation of arteriolar smooth muscle can reduce systemic vascular resistance, arterial systolic pressure and mean arterial pressure (afterload). It can also dilate coronary arteries.

More

Relaxation of vascular smooth muscle, which in turn causes dilation of peripheral arteries and veins, has a stronger dilation effect on venous vessels. Venous dilation can promote peripheral blood aggregation and reduce venous return, thereby reducing ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Relaxation of arteriolar smooth muscle can reduce systemic vascular resistance, arterial systolic pressure and mean arterial pressure (afterload). It can also dilate coronary arteries.

87-33-2 23
1,4:3,6-dianhydro-D-sorbitol dinitrate (isosorbide dinitrate)

Relaxation of vascular smooth muscle causes dilation of peripheral arteries and veins, with a stronger dilation effect on venous vessels. Venous dilation can promote peripheral blood aggregation and reduce venous return, thereby reducing ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Relaxation of arteriolar smooth muscle can reduce systemic vascular resistance, arterial systolic pressure and mean arterial pressure (afterload). It can also dilate coronary arteries.

More

Relaxation of vascular smooth muscle causes dilation of peripheral arteries and veins, with a stronger dilation effect on venous vessels. Venous dilation can promote peripheral blood aggregation and reduce venous return, thereby reducing ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Relaxation of arteriolar smooth muscle can reduce systemic vascular resistance, arterial systolic pressure and mean arterial pressure (afterload). It can also dilate coronary arteries.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.